The use of medical hyperspectral technology to evaluate microcirculatory changes in diabetic foot ulcers and to predict clinical outcomes

Diabetes Care

Volumn 30, Issue 4, 2007, Pages 903-910

  Khaodhiar, Lalita ^a   Dinh, Thanh ^a   Schomacker, Kevin T ^b   Panasyuk, Svetlana V ^b   Freeman, Jenny E ^b   Lew, Robert ^c   Vo, Tiffany ^a   Panasyuk, Alexander A ^b   Lima, Christina ^a   Giurini, John M ^a   Lyons, Thomas E ^a   Veves, Aristidis ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HyperMed Inc   (United States)

^c BOSTON UNIVERSITY   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYHEMOGLOBIN; OXYHEMOGLOBIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC FOOT; DIAGNOSTIC PROCEDURE; FEMALE; FOOT ULCER; HUMAN; IMAGING; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MEDICAL TECHNOLOGY; MICROANGIOPATHY; OUTCOME ASSESSMENT; SENSITIVITY AND SPECIFICITY; SPECTROMETRY; WOUND HEALING;

ADULT; AGED; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC FOOT; DIABETIC NEUROPATHIES; FEMALE; FOOT ULCER; HUMANS; IMAGE ENHANCEMENT; MALE; MICROCIRCULATION; MICROSCOPY, FLUORESCENCE, MULTIPHOTON; MIDDLE AGED; OXYGEN CONSUMPTION; REFERENCE VALUES; SKIN; TECHNOLOGY, MEDICAL; TREATMENT OUTCOME; WOUND HEALING;

EID: 34147190439     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-2209     Document Type: Article

References (17)

1. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, Wagner EH: Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care 22:382-387, 1999
2. Frykberg RG, Zgonis T, Armstrong DG, Driver VR, Giurini JM, Kravitz SR, Landsman AS, Lavery LA, Moore JC, Schuberth JM, Wukich DK, Andersen C, Vanore JV: Diabetic foot disorders: a clinical practice guideline (2006 revision). J Foot Ankle Surg 45 (Suppl. 5):S2-S66, 2006
3. Margolis DJ, Kantor J, Berlin JA: Healing of diabetic neuropathic foot ulcers receiving standard treatment: a meta-analysis. Diabetes Care 22:692-695, 1999
4. Veves A, Falanga V, Armstrong DG, Sabolinski ML: Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 24:290-295, 2001
5. Veves A, Sheehan P, Pham HT: A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs. standard treatment in the management of diabetic foot ulcers. Arch Surg 137:822-827, 2002
6. American Diabetes Association: Consensus development conference on diabetic foot wound care: 7-8 April 1999, Boston, Massachusetts. Diabetes Care 22:1354-1360, 1999
7. Sheehan P, Jones P, Caselli A, Giurini JM, Veves A: Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care 26:1879-1882, 2003
8. Greenman RI, Panasyuk S, Wang X, Lyons TE, Dinh T, Longorio L, Giurini JM, Freeman J, Khaodhiar L, Veves A: Early changes in the skin microcirculation and muscle metabolism of the diabetic foot. Lancet 366:1711-1718, 2005
9. Gillies R, Freeman JE, Cancio LC, Brand D, Hopmeier M, Mansfield JR: Systemic effects of shock and resuscitation monitored by visible hyperspectral imaging. Diab Technol Therapeut 5:847-855, 2003
10. Expert Committee on the Diagnosis and Classificatin of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26 (Suppl. 1):S5-S20, 2006
11. American Diabetes Association: 1988 report and recommendations of the San Antonio Conference on Diabetic Neuropathy (Consensus Statement). Diabetes 37:1000-1004, 1988
12. Pham H, Armstrong DG, Harvey C, Harkless LB, Giurini JM, Veves A: Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. Diabetes Care 23:606-611, 2000
13. Colarusso P, Kidder LH, Levin IW, Fraser JC, Arens JF, Lewis EN: Infrared spectroscopic imaging: from planetary to cellular systems. Appl Spectrosc 52:106A-120A, 1998
14. Arora S, Smakowski P, Frykberg RG, Simeone LR, Freeman R, LoGerfo FW, Veves A: Differences in foot and forearm skin microcirculation in diabetic patients with and without neuropathy. Diabetes Care 21:1339-1344, 1998
15. Jeffcoate WJ, Chipchase SY, Ince P, Game FL: Assessing the outcome of the management of diabetic foot ulcers using ulcerrelated and person-related measures. Diabetes Care 29:1784-1787, 2006
16. Caselli A, Rich J, Hanane T, Uccioli L, Veves A: Role of C-nociceptive fibers in the nerve axon reflex-related vasodilation in diabetes. Neurology 60:297-300, 2003
17. Stansberry KB, Peppard HR, Babyak LM, Popp G, McNitt PM, Vinik AI: Primary nociceptive afferents mediate the blood flow dysfunction in non-glabrous (hairy) skin of type 2 diabetes: a new model for the pathogenesis of microvascular dysfunction. Diabetes Care 22:1549-1554, 1999